Nantahala Capital Management
Tracked across 2 events · 13 articles · First seen Apr 14, 2026 · Last active Aug 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Femasys Inc., a biomedical company developing fertility and non-surgical permanent birth control solutions, announced on August 7, 2026 that it entered into a securities purchase agreement for a $30 million private placement with accredited investors.…
Impact: Nantahala Capital Management led the private placement as the new institutional investor, demonstrating confidence in Femasys' strategy and technologies.
Aug 07, 2026 · 6 articles
Business
Impact: Nantahala Capital Management is one of the new investors participating in the $350 million private placement financing for the combined Galera Therapeutics and Obsidian Therapeutics, Inc. entity.
Apr 14, 2026 · 7 articles
80
Nantahala Capital Management led financing Femasys Inc.Femasys $30M Private...
ERGEN INTELLIGENCE
Track Nantahala Capital Management live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard